Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Allogenic Adipose Tissue-derived Mesenchymal Stromal Cells for the Treatment of Primary Progressive Multiple Sclerosis [Phase 1]
A Phase 1 clinical trial investigating allogeneic adipose tissue–derived mesenchymal stromal cells for primary progressive multiple sclerosi…
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: A Phase IIa Study of Vitamin D3 Tolerogenic Dendritic Cells (tolDC) for Multiple Sclerosis [Phase 2]
A Phase IIa clinical trial evaluating Vitamin D3 tolerogenic dendritic cells for multiple sclerosis; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Eccentric Cycling in Multiple Sclerosis Rehabilitation [NA]
This clinical trial investigates eccentric cycling as a rehabilitation modality for people with multiple sclerosis; the study is not yet rec…
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: French Registry for Monitoring Pregnancies for Multiple Sclerosis
A French registry is being established to monitor pregnancies in people with multiple sclerosis and related demyelinating disorders (NMOSD a…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: Escalation vs. Induction Therapy Strategy in Patients With Early-Onset MS After Age 50
This clinical trial update outlines a study comparing escalation versus induction therapy strategies in patients with multiple sclerosis dia…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Role of Urinary Sphingosine 1-Phosphate as a Biomarker for Detrusor Hyperactivity in Multiple Sclerosis
This clinical trial investigates urinary sphingosine-1-phosphate as a biomarker for detrusor hyperactivity in people with multiple sclerosis…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Effects of Laughter Yoga on Fatigue, Sleep Quality and Psychological Well-Being in Patients With Multiple Sclerosis: A Randomized Controlled Trial [NA]
This is a completed randomized controlled trial evaluating whether laughter yoga improves fatigue, sleep quality, and psychological well-bei…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Normal Chinese Lifespan Brain Charts Initiative (NCLBCI)
Beijing Tiantan Hospital is conducting an ongoing enrollment study to establish normal Chinese lifespan brain charts, enrolling by invitatio…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases [NA]
A Mayo Clinic-led clinical trial investigates breathing practices to support brain and mental health in cancer and neurodegenerative disease…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Implementation of an Advanced Telerehabilitation Solution for People With Multiple Sclerosis [Phase 2]
Phase 2 clinical trial update on implementing an advanced telerehabilitation solution for people with multiple sclerosis.
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Smoldering Inflammation in MS
A clinical trial at Washington University School of Medicine is investigating smoldering inflammation in people with multiple sclerosis and …
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
A prospective investigation of Multiple Sclerosis in the Three Rivers Region is currently recruiting participants, sponsored by the Universi…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis (Switzerland)
This entry summarizes an ongoing, recruiting prospective cohort study (Clinnova-MS) evaluating outcomes in people with multiple sclerosis in…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Multiple Sclerosis Versus Neuromyelitis Optica Spectrum Disorder
A clinical trial update from Assiut University describes a study comparing multiple sclerosis and neuromyelitis optica spectrum disorder, wi…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Individualised Cryoneurolysis to Treat Pain in the Context of Spasticity in the Upper and Lower Extremities [Phase 4]
A Phase 4 clinical trial is evaluating individualized cryoneurolysis to manage pain in the context of spasticity in the upper and lower extr…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Intermediate Expanded Access Protocol CNMAu8.EAP03
Clene Nanomedicine's intermediate expanded access protocol CNMAu8.EAP03 for CNM-Au8 in multiple sclerosis is temporarily not available. No c…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: This Study Involves a Positron Emission Tomography (PET) Scan Using a New Investigational Radioactive Tracer, [18F]-FZTA, to Detect Inflammation in the Brain. The Tracer Will be Tested in Healthy Younger Adults and Individuals With Multiple Sclerosis.
A clinical trial is evaluating a new PET radiotracer, [18F]-FZTA, to detect brain inflammation and will enroll healthy young adults and indi…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Transcutaneous Tibial Neuro-stimulation to Improve Voiding Dysfunction in Multiple Sclerosis. [NA]
A clinical trial in recruitment is studying transcutaneous tibial neuro-stimulation to improve voiding dysfunction in individuals with multi…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Project BIPAMS: Behavioral Intervention for Physical Activity in Multiple Sclerosis [NA]
This clinical trial update notes an active non-recruiting study (Project BIPAMS) evaluating a behavioral intervention to increase physical a…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years [Phase 2]
Phase 2 clinical trial to evaluate relapse prevention in multiple sclerosis using mRNA-1195 versus placebo; currently recruiting in adults a…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Behavioral Intervention for Physical Activity and Sexual Dysfunction in Multiple Sclerosis [NA]
Clinical trial update from University of Alabama at Birmingham on a behavioral intervention for improving physical activity and addressing s…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Disease Progression in ms
A not-yet-recruiting clinical trial led by Hüseyin Bektaş aims to predict disease progression in multiple sclerosis.
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Motor Learning of Fall Resistant Skills Through Slip and Trip Exposure in Multiple Sclerosis [NA]
This clinical trial update notes ongoing recruitment for a study assessing motor learning to improve fall resistance in relapsing-remitting …
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Walking Fatigability and Brain Activity in People With Multiple Sclerosis
Clinical trial update from Hasselt University on walking fatigability and brain activity in people with Multiple Sclerosis; the study is cur…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune Diseases [EARLY_Phase 1]
A Phase 1 trial evaluating a universal CAR T-cell therapy targeting CD19 and BCMA in relapsed/refractory neurological autoimmune diseases, w…